BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34021168)

  • 1. β-Galactosidase is a target enzyme for detecting peritoneal metastasis of gastric cancer.
    Kubo H; Murayama Y; Ogawa S; Matsumoto T; Yubakami M; Ohashi T; Kubota T; Okamoto K; Kamiya M; Urano Y; Otsuji E
    Sci Rep; 2021 May; 11(1):10664. PubMed ID: 34021168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid fluorescence imaging of human hepatocellular carcinoma using the β-galactosidase-activatable fluorescence probe SPiDER-βGal.
    Ogawa S; Kubo H; Murayama Y; Kubota T; Yubakami M; Matsumoto T; Yamamoto Y; Morimura R; Ikoma H; Okamoto K; Kamiya M; Urano Y; Otsuji E
    Sci Rep; 2021 Sep; 11(1):17946. PubMed ID: 34504174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A topically-sprayable, activatable fluorescent and retaining probe, SPiDER-βGal for detecting cancer: Advantages of anchoring to cellular proteins after activation.
    Nakamura Y; Mochida A; Nagaya T; Okuyama S; Ogata F; Choyke PL; Kobayashi H
    Oncotarget; 2017 Jun; 8(24):39512-39521. PubMed ID: 28467810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic fluorescent imaging with the activatable probe, γ-glutamyl hydroxymethyl rhodamine green in the detection of peritoneal cancer metastases: Overcoming the problem of dilution when using a sprayable optical probe.
    Nakamura Y; Harada T; Nagaya T; Sato K; Okuyama S; Choyke PL; Kobayashi H
    Oncotarget; 2016 Aug; 7(32):51124-51137. PubMed ID: 27286461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive β-galactosidase-targeting fluorescence probe for visualizing small peritoneal metastatic tumours in vivo.
    Asanuma D; Sakabe M; Kamiya M; Yamamoto K; Hiratake J; Ogawa M; Kosaka N; Choyke PL; Nagano T; Kobayashi H; Urano Y
    Nat Commun; 2015 Mar; 6():6463. PubMed ID: 25765713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloprotease-14 is a target enzyme for detecting peritoneal metastasis in gastric cancer.
    Ogawa S; Kubo H; Murayama Y; Kubota T; Yubakami M; Matsumoto T; Ohashi T; Okamoto K; Kuriki Y; Hanaoka K; Urano Y; Otsuji E
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102420. PubMed ID: 34242818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senescent Fibroblasts Potentiate Peritoneal Metastasis of Diffuse-type Gastric Cancer Cells
    Li Y; Tazawa H; Nagai Y; Fujita S; Okura T; Shoji R; Yamada M; Kikuchi S; Kuroda S; Ohara T; Noma K; Nishizaki M; Kagawa S; Fujiwara T
    Anticancer Res; 2024 Jun; 44(6):2497-2509. PubMed ID: 38821603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
    Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
    PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New whole-body multimodality imaging of gastric cancer peritoneal metastasis combining fluorescence imaging with ICG-labeled antibody and MRI in mice.
    Ito A; Ito Y; Matsushima S; Tsuchida D; Ogasawara M; Hasegawa J; Misawa K; Kondo E; Kaneda N; Nakanishi H
    Gastric Cancer; 2014; 17(3):497-507. PubMed ID: 24288123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
    Kiyozumi Y; Iwatsuki M; Kurashige J; Ogata Y; Yamashita K; Koga Y; Toihata T; Hiyoshi Y; Ishimoto T; Baba Y; Miyamoto Y; Yoshida N; Yanagihara K; Mimori K; Baba H
    Int J Cancer; 2018 Sep; 143(5):1202-1211. PubMed ID: 29603227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis.
    Okugawa Y; Toiyama Y; Hur K; Toden S; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Kusunoki M; Boland CR; Goel A
    Carcinogenesis; 2014 Dec; 35(12):2731-9. PubMed ID: 25280565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A β-Galactosidase-Activated Fluorogenic Reporter for the Detection of Gastric Cancer In Vivo and in Urine.
    Yu M; Meng Z; Yi S; Chen J; Xu W; Ruan B; Wang J; Han F; Huang J
    Anal Chem; 2024 Apr; 96(16):6390-6397. PubMed ID: 38608159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicle derived miR-544 downregulates expression of tumor suppressor promyelocytic leukemia zinc finger resulting in increased peritoneal metastasis in gastric cancer.
    Kong W; Liu X; Yin G; Zheng S; Zhu A; Yu P; Shan Y; Ying R; Zhang J
    Aging (Albany NY); 2020 Nov; 12(23):24009-24022. PubMed ID: 33221764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new near-infrared excitation/emission fluorescent probe for the detection of β-galactosidase in living cells and in vivo.
    Li Y; Liu F; Zhu D; Zhu T; Zhang Y; Li Y; Luo J; Kong L
    Talanta; 2022 Jan; 237():122952. PubMed ID: 34736678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-autophagy axis induces VEGFA by peritoneal mesothelial cells to promote gastric cancer peritoneal metastasis through an integrin α5-fibronectin pathway.
    Wang X; Che X; Yu Y; Cheng Y; Bai M; Yang Z; Guo Q; Xie X; Li D; Guo M; Hou K; Guo W; Qu X; Cao L
    J Exp Clin Cancer Res; 2020 Oct; 39(1):221. PubMed ID: 33081836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of SYT8 For the Detection, Prediction, and Treatment of Peritoneal Metastasis From Gastric Cancer.
    Kanda M; Shimizu D; Tanaka H; Tanaka C; Kobayashi D; Hayashi M; Iwata N; Niwa Y; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
    Ann Surg; 2018 Mar; 267(3):495-503. PubMed ID: 28026832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo imaging of intraperitoneally disseminated tumors in model mice by using activatable fluorescent small-molecular probes for activity of cathepsins.
    Fujii T; Kamiya M; Urano Y
    Bioconjug Chem; 2014 Oct; 25(10):1838-46. PubMed ID: 25196809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-C motif chemokine 22 ligand (CCL22) concentrations in sera of gastric cancer patients are related to peritoneal metastasis and predict recurrence within one year after radical gastrectomy.
    Wei Y; Wang T; Song H; Tian L; Lyu G; Zhao L; Xue Y
    J Surg Res; 2017 May; 211():266-278. PubMed ID: 28501127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10.
    Zheng J; Ge P; Liu X; Wei J; Wu G; Li X
    Tumour Biol; 2017 Jun; 39(6):1010428317706207. PubMed ID: 28656883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive fluorescent probe for β-galactosidase activity detection and application in ovarian tumor imaging.
    Fan F; Zhang L; Zhou X; Mu F; Shi G
    J Mater Chem B; 2021 Jan; 9(1):170-175. PubMed ID: 33230516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.